866-997-4948(US-Canada Toll Free)

Oligonucleotide Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 187 Pages

Global Oligonucleotide Synthesis Market: Overview 

The oligonucleotide synthesis market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on genetics and genomics in the research and diagnostics applications, and rising application of oligonucleotides in therapeutics. 

The market overview section of the report comprises qualitative analysis of the overall oligonucleotide synthesis market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, market opportunity analysis for product for global as well as Asia Pacific has also been provided. The report also comprises applications of oligonucleotides, and PEST analysis.

Global Oligonucleotide Synthesis Market: Segmentation 

The global oligonucleotide synthesis market has been segmented on the basis of product, application and end user. The product segment is further segmented as, reagents & consumables, equipment, and synthesized oligonucleotide. The synthesized oligonucleotide segment is further segmented as, DNA oligonucleotides, RNA oligonucleotides, and others. Synthesized oligonucleotide segment accounted major share in 2016 of oligonucleotide synthesis market and expected to register high CAGR over forecast period. 

By application, the global oligonucleotide synthesis market is segmented as, research, therapeutics, and diagnostics. The research accounted major share in 2016 of oligonucleotide synthesis market. The segment is further segmented as, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NSG), and others. The therapeutic segment is fast growing segment by application over the forecast period owing to rising application of oligonucleotides in therapeutics. The segment is further segmented as antisense oligonucleotides, and nucleic acid aptamers. In market only few drugs are approved for therapeutic purpose and more than 100 are in various stages of clinical trials. 

On the basis of end user, the global oligonucleotide synthesis market is segmented as biotechnology & pharmaceutical companies, research institutes, and diagnostic laboratories. Research institutes segment accounted major share in 2016 by end user in global oligonucleotide synthesis market. The biotechnology and pharmaceutical companies segment is expected to register high CAGR over forecast period. Increasing research and development activities, and rising demand for new drug development for rare and genetic disease is expected to drive growth of biotechnology and pharmaceutical companies segment over the forecast period. Moreover, rising application of oligonucleotides in diagnostics is expected to drive the growth of diagnostics segment over the forecast period. 

The market for these product, application and end user has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, and geographic presence of major market players and their product developments. The market size and forecast in terms of revenue (US$ million), for each of these segments, and the sub-segments have been provided for the period 2015 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2017 to 2025. 

Geographically, the oligonucleotide synthesis market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size forecast for each region has been provided for the period 2015 to 2025, in terms of product, application and end user, along with the CAGR (%) for the forecast period 2017 to 2025. 

Global Oligonucleotide Synthesis Market: Competitive Analysis 

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global oligonucleotide synthesis market, in terms of percentage share in 2016 has been provided. The report concludes with the profiles of major players in the global oligonucleotide synthesis market such as Thermo Fisher Scientific, Sigma-Aldrich Corporation (a part of Merck KGaA), Integrated DNA Technologies, GE Healthcare, Kaneka Eurogentec S.A., Agilent Technologies, Applied Biosystems, BioAutomation, Eurofins Genomics, Gene Design, Inc. among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments. 

The global Oligonucleotide Synthesis market is segmented as given below: 

Oligonucleotide Synthesis Market, by Product Type

  • Reagents & Consumables
  • Equipment
  • Synthesized oligonucleotides
  • DNA oligonucleotides
  • RNA oligonucleotides
  • Others

Oligonucleotide Synthesis Market, by Application

  • Research
  • Polymerase Chain Reaction
  • Next Generation Sequencing
  • Others
  • Therapeutics
  • Antisense Oligonucleotides
  • Nucleic Acid Aptamers
  • Diagnostics

Oligonucleotide Synthesis Market, by End-users               

  • Biotechnology & Pharmaceutical Companies
  • Research Institutes
  • Diagnostic Laboratories

Global Oligonucleotide Synthesis Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oligonucleotide Synthesis Market

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, 2015–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Oligonucleotide Synthesis Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook
4.10. Applications of Oligonucleotides
4.11. PEST Analysis
4.12. Pipeline Analysis

5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Product Type 
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast by Product Type, 2015–2025
5.4.1. Reagents & Consumables
5.4.2. Equipment
5.4.3. Synthesized oligonucleotides
5.4.3.1. DNA Oligonucleotides 
5.4.3.2. RNA Oligonucleotides 
5.4.3.3. Others
5.5. Market Attractiveness by Product Type

6. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Application 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast by Application, 2015–2025
6.4.1. Research
6.4.1.1. Polymerase Chain Reaction 
6.4.1.2. Next Generation Sequencing 
6.4.1.3. Others
6.4.2. Therapeutics 
6.4.2.1. Antisense Oligonucleotides
6.4.2.2. Nucleic Acid Aptamers
6.4.3. Diagnostics
6.5. Market Attractiveness by Application

7. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By End User 
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Value Forecast by End User, 2015–2025
7.4.1. Biotechnology & Pharmaceutical Companies 
7.4.2. Research Institutes 
7.4.3. Diagnostic Laboratories 
7.5. Market Attractiveness by End User

8. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value Forecast by Region
8.3.1. North America 
8.3.2. Europe 
8.3.3. Asia Pacific 
8.3.4. Latin America 
8.3.5. Middle East & Africa 
8.4. Market Attractiveness by Country/Region

9. North America Oligonucleotide Synthesis Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Key Trends
9.2. Market Value Forecast by Product Type, 2015–2025
9.2.1. Reagents & Consumables
9.2.2. Equipment
9.2.3. Synthesized oligonucleotides
9.2.3.1. DNA Oligonucleotides 
9.2.3.2. RNA Oligonucleotides 
9.2.3.3. Others
9.3. Market Value Forecast by Application, 2015–2025
9.3.1. Research 
9.3.1.1. Polymerase Chain Reaction 
9.3.1.2. Next Generation Sequencing 
9.3.1.3. Others
9.3.2. Therapeutics 
9.3.2.1. Antisense Oligonucleotides
9.3.2.2. Nucleic Acid Aptamers
9.3.3. Diagnostics
9.4. Market Value Forecast by End User, 2015–2025
9.4.1. Biotechnology & Pharmaceutical Companies 
9.4.2. Research Institutes 
9.4.3. Diagnostic Laboratories 
9.5. Market Value Forecast by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis 
9.6.1. By Product Type 
9.6.2. By Application 
9.6.3. By End User 
9.6.4. By Country

10. Europe Oligonucleotide Synthesis Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Key Trends
10.2. Market Value Forecast by Product Type, 2015–2025
10.2.1. Reagents & Consumables
10.2.2. Equipment
10.2.3. Synthesized oligonucleotides
10.2.3.1. DNA Oligonucleotides 
10.2.3.2. RNA Oligonucleotides 
10.2.3.3. Others
10.3. Market Value Forecast by Application, 2015–2025
10.3.1. Research 
10.3.1.1. Polymerase Chain Reaction 
10.3.1.2. Next Generation Sequencing 
10.3.1.3. Others
10.3.2. Therapeutics 
10.3.2.1. Antisense Oligonucleotides
10.3.2.2. Nucleic Acid Aptamers
10.3.3. Diagnostics
10.4. Market Value Forecast by End User, 2015–2025
10.4.1. Biotechnology & Pharmaceutical Companies 
10.4.2. Research Institutes 
10.4.3. Diagnostic Laboratories 
10.5. Market Value Forecast by Country, 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy 
10.5.5. Spain 
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis 
10.6.1. By Product Type 
10.6.2. By Application 
10.6.3. By End User 
10.6.4. By Country

11. Asia Pacific Oligonucleotide Synthesis Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Key Trends
11.2. Market Value Forecast by Product Type, 2015–2025
11.2.1. Reagents & Consumables
11.2.2. Equipment
11.2.3. Synthesized oligonucleotides
11.2.3.1. DNA Oligonucleotides 
11.2.3.2. RNA Oligonucleotides 
11.2.3.3. Others
11.3. Market Value Forecast by Application, 2015–2025
11.3.1. Research 
11.3.1.1. Polymerase Chain Reaction 
11.3.1.2. Next Generation Sequencing 
11.3.1.3. Others
11.3.2. Therapeutics 
11.3.2.1. Antisense Oligonucleotides
11.3.2.2. Nucleic Acid Aptamers
11.3.3. Diagnostics
11.4. Market Value Forecast by End User, 2015–2025
11.4.1. Biotechnology & Pharmaceutical Companies 
11.4.2. Research Institutes 
11.4.3. Diagnostic Laboratories 
11.5. Market Value Forecast by Country, 2015–2025
11.5.1. China
11.5.2. India
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific 
11.6. Market Attractiveness Analysis 
11.6.1. By Product Type 
11.6.2. By Application 
11.6.3. By End User 
11.6.4. By Country

12. Latin America Oligonucleotide Synthesis Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Key Trends
12.2. Market Value Forecast by Product Type, 2015–2025
12.2.1. Reagents & Consumables
12.2.2. Equipment
12.2.3. Synthesized oligonucleotides
12.2.3.1. DNA Oligonucleotides 
12.2.3.2. RNA Oligonucleotides 
12.2.3.3. Others
12.3. Market Value Forecast by Application, 2015–2025
12.3.1. Research 
12.3.1.1. Polymerase Chain Reaction 
12.3.1.2. Next Generation Sequencing 
12.3.1.3. Others
12.3.2. Therapeutics 
12.3.2.1. Antisense Oligonucleotides
12.3.2.2. Nucleic Acid Aptamers
12.3.3. Diagnostics
12.4. Market Value Forecast by End User, 2015–2025
12.4.1. Biotechnology & Pharmaceutical Companies
12.4.2. Research Institutes 
12.4.3. Diagnostic Laboratories 
12.5. Market Value Forecast by Country, 2015–2025
12.5.1. Brazil 
12.5.2. Mexico
12.5.3. Rest of Latin America 
12.6. Market Attractiveness Analysis 
12.6.1. By Product Type 
12.6.2. By Application 
12.6.3. By End User 
12.6.4. By Country

13. Middle East & Africa Oligonucleotide Synthesis Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.1.3. Key Trends
13.2. Market Value Forecast by Product Type, 2015–2025
13.2.1. Reagents & Consumables
13.2.2. Equipment
13.2.3. Synthesized oligonucleotides
13.2.3.1. DNA Oligonucleotides 
13.2.3.2. RNA Oligonucleotides 
13.2.3.3. Others
13.3. Market Value Forecast by Application, 2015–2025
13.3.1. Research 
13.3.1.1. Polymerase Chain Reaction 
13.3.1.2. Next Generation Sequencing 
13.3.1.3. Others
13.3.2. Therapeutics 
13.3.2.1. Antisense Oligonucleotides
13.3.2.2. Nucleic Acid Aptamers
13.3.3. Diagnostics
13.4. Market Value Forecast by End User, 2015–2025
13.4.1. Biotechnology & Pharmaceutical Companies 
13.4.2. Research Institutes 
13.4.3. Diagnostic Laboratories 
13.5. Market Value Forecast by Country, 2015–2025
13.5.1. Saudi Arabia
13.5.2. South Africa
13.5.3. UAE
13.5.4. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis 
13.6.1. By Product Type 
13.6.2. By Application 
13.6.3. By End User 
13.6.4. By Country

14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis by Company (2016)
14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. GE Healthcare
14.3.1.1. Financial Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Thermo Fisher Scientific 
14.3.2.1. Financial Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Agilent Technologies, Inc. 
14.3.3.1. Financial Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Merck KGaA 
14.3.4.1. Financial Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Integrated DNA Technologies, Inc.
14.3.5.1. Financial Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Kaneka Eurogentec S.A. (Kaneka Corporation) 
14.3.6.1. Financial Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. TriLink BioTechnologies,LLC (Maravai Life Sciences) 
14.3.7.1. Financial Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. BioAutomation
14.3.8.1. Financial Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. ATDBio Ltd.
14.3.9.1. Financial Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Gene Design, Inc. 
14.3.10.1. Financial Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. Eurofins Genomics
14.3.11.1. Financial Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview

List of Table

Table 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 03: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 04: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 05: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 06: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 11: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 13: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 14: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 17: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 18: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 19: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 20: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 21: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 22: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 24: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 25: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 26: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 27: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 28: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 29: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 30: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 31: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 32: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 34: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 35: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 36: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 37: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 38: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 39: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 40: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 41: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 42: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

List of Chart

Figure 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Global oligonucleotide Synthesis Market Value Share, by Product Type (2016)
Figure 03: Global oligonucleotide Synthesis Market Value Share, by Application (2016)
Figure 04: Global oligonucleotide Synthesis Market Value Share, by End User (2016)
Figure 05: Global oligonucleotide Synthesis Market Value Share, by Region (2016)
Figure 06: Global Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 07: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents & Consumables, 2015–2025
Figure 08: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equipment, 2015–2025
Figure 09: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthesized Oligonucleotides, 2015–2025
Figure 10: Global Oligonucleotide Synthesis Market Attractiveness, by Product Type
Figure 11: Global Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 12: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research, 2015–2025
Figure 13: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2015–2025
Figure 14: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2015–2025
Figure 15: Global Oligonucleotide Synthesis Market Attractiveness, by Application 
Figure 16: Global Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 17: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2015–2025
Figure 18: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research Institutes, 2015–2025
Figure 19: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2015–2025
Figure 20: Global Oligonucleotide Synthesis Market Attractiveness, by End-user 
Figure 21: Global Oligonucleotide Synthesis Market Value Share, by Region, 2017 and 2025 
Figure 22: Global Oligonucleotide Synthesis Market Attractiveness, by Region, 2017–2025
Figure 23: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 24: North America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 25: North America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 26: North America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 27: North America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 28: North America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 29: North America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 30: North America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 31: North America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 32: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 33: Europe Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 34: Europe Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 35: Europe Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 36: Europe Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 37: Europe Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 38: Europe Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 39: Europe Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 40: Europe Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 41: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 42: Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 43: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 44: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 45: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 46: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 47: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 48: Asia Pacific Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 49: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 50: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 51: Latin America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 52: Latin America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 53: Latin America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 54: Latin America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 55: Latin America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 56: Latin America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 57: Latin America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 58: Latin America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 59: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 60: Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 61: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Country, 2017–2025
Figure 62: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 63: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017–2025
Figure 64: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 65: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Application, 2017–2025
Figure 66: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 67: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017–2025
Figure 68: Global Oligonucleotide Synthesis Market Share, by Company, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *